Tony Goodman's most recent trade in Adial Pharmaceuticals Inc was a trade of 26,510 Common Stock done . Disclosure was reported to the exchange on April 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharma Inc | Tony Goodman | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 26,510 | 26,523 (0%) | 0% | 0 | Common Stock | |
| Adial Pharma Inc | Tony Goodman | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 94,000 | 94,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | Tony Goodman | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | Tony Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Adial Pharma Inc | Tony Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option | |
| Adial Pharma Inc | Tony Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option |